<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The relationship between <z:e sem="disease" ids="C0473527" disease_type="Disease or Syndrome" abbrv="">hypoalphalipoproteinemia</z:e> (hypoalpha), a <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolic disorder</z:e> characterized by reduced <z:chebi fb="6" ids="39025">high-density lipoprotein</z:chebi> (<z:chebi fb="17" ids="39025">HDL</z:chebi>) cholesterol levels, and atherosclerotic disease is not completely understood </plain></SENT>
<SENT sid="1" pm="."><plain>We investigated arterial functional and structural changes in 19 subjects with hypoalpha (<z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> &lt; or = 0.7 mmol/L for men and &lt; or = 0.8 mmol/L for women; 13 men; 47 +/- 7 years) and in 21 healthy control subjects (11 men; 46 +/- 13 years) </plain></SENT>
<SENT sid="2" pm="."><plain>Brachial-artery flow-mediated vasodilation (FMV) and intima-media thickness (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>) of the carotid and femoral arteries were determined in <z:hpo ids='HP_0000001'>all</z:hpo> subjects </plain></SENT>
<SENT sid="3" pm="."><plain>FMV was significantly lower in hypoalpha than in controls (5.6% +/- 4.3% v 8.2% +/- 2.7%; P &lt;.05) </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> was greater in hypoalpha than in controls at both the internal carotid (0.83 +/- 0.1 mm v 0.69 +/- 0.1 mm) and superficial femoral level (0.83 +/- 0.2 mm v 0.68 +/- 0.1 mm; both P &lt;.05) </plain></SENT>
<SENT sid="5" pm="."><plain>FMV had a positive correlation with <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> (r =.42, P =.06) and a negative one with <z:chebi fb="4" ids="17855">triglycerides</z:chebi> (r = -0.38, P =.01) </plain></SENT>
<SENT sid="6" pm="."><plain>An inverse relationship was found between <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> and internal carotid and superficial femoral <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> (r = -0.64 and r = -0.60, respectively; P &lt;.01 for both) and a positive one between <z:chebi fb="4" ids="17855">triglycerides</z:chebi> and internal carotid and superficial femoral <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> (r =.53 and r =.47, P &lt;.05) </plain></SENT>
<SENT sid="7" pm="."><plain>In a multivariate regression analysis, brachial FMV was predicted by <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> and brachial diameter (beta =.42 and -0.43, respectively; both P &lt;.05) </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> was the only significant predictor of internal carotid and superficial femoral <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> (beta = -0.45 and -0.49, respectively; both P &lt;.05) </plain></SENT>
<SENT sid="9" pm="."><plain>In conclusion, subjects with primary hypoalpha, without overt <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e>, are characterized by an impaired endothelial function and by an increase in large-artery <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> </plain></SENT>
</text></document>